Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects

Two pathogenetic types of endometrial carcinoma

Jan V. Bokhman · Gynecologic Oncology · 1983 · 2.5K citations

Endocrine-related Cancer, Endometriosis, Gynecology +6

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

Elisabete Weiderpass, Hans‐Olov Adami, John A. Baron et al. · JNCI Journal of the National Cancer Institute · 1999 · 472 citations · Full text

Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40

Thomas C. Randall, R. J. Kurman · Obstetrics and Gynecology · 1997 · 432 citations · Full text

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Peter G. Rose, Virginia L. Brunetto, Linda Vanle et al. · Gynecologic Oncology · 2000 · 201 citations

Advanced Recurrent, Phase Ii Trial, Medicine +5

Biological Significance of Aromatase Activity in Human Breast Tumors*

NANCY TILSON-MALLETT, Steven J. Santner, Peter D. Feil et al. · The Journal of Clinical Endocrinology & Metabolism · 1983 · 132 citations